If you are having problems accessing, please clear your browser data (cache and cookies) for the last 4 weeks and try again. If you are still having problems, please contact us at +47 21 555 888.

Stocks

The table gives an overview of all stocks, alphabetically sorted.

Show advanced options
 Abionyx Pharma 609 Apr 25, 2025 1.16 +3.20   
 Abitare In Spa 1BN Apr 25, 2025 3.06 +2.85   
 ABITIBI METALS CORP. FW0 Apr 25, 2025 0.16 -3.27   
 Abivax 2X1 Apr 25, 2025 5.97 +14.59   
 ABIVAX SA SP.ADR EO -,01 2X10 Apr 25, 2025 5.90 +16.83   
 ABL Group ASA 26Q Apr 25, 2025 0.79 +5.63   
 ABM Industries Incorporated AB4 Apr 25, 2025 42.40 +5.47   
 ABM INVESTAMA TBK RP 100 0A1 Apr 25, 2025 0.17 +3.73   
 ABN AMRO Bank N.V. AB2 Apr 25, 2025 17.96 +4.00   
 ABN AMRO BK.UNSP.ADR/1 AB2A Apr 25, 2025 17.50 -2.23   
 ABO Wind AG AB9 Apr 25, 2025 41.80 +0.97   
 ABO-Group 3T61 Apr 25, 2025 4.92 -6.29   
 ABOUT YOU HLDG Z.VERK. YOU0 Apr 25, 2025 6.26 0.00   
 ABOUT YOU HOLDING AG YOU Apr 25, 2025 6.69 0.00   
 Absa Group Limited AU61 Apr 25, 2025 7.70 -1.91   
 ABSOLICON SOLAR COLLEC. B ZY0 Apr 25, 2025 0.24 -4.69   
 AC Immune SA IMR Apr 25, 2025 1.40 +11.31   
 Acacia Research Corporation AZG2 Apr 25, 2025 2.80 +10.24   
 AcadeMedia V8T Apr 25, 2025 7.29 +2.39   
 Acadia Healthcare Company, Inc. 7RA Apr 25, 2025 19.50 -7.14   
 ACADIA Pharmaceuticals Inc. DR6 Apr 25, 2025 13.03 +1.68   
 Acadia Realty Trust WX1 Apr 25, 2025 17.20 -1.71   
 Acadian Timber Corp 779 Apr 25, 2025 10.60 +0.95   
 Acanthe Developpement SA ADX Apr 25, 2025 0.29 +1.75   
 Acarix 7AC Apr 25, 2025 0.02 -11.94   
 Acast AB 0PN Apr 25, 2025 1.20 +3.98   
 Accelerate Diagnostics 1A80 Apr 25, 2025 0.48 -0.42   
 ACCELLERON IND. ADR/1 ZH20 Apr 25, 2025 43.40 +5.85   
 Accent Resources NL A2R Apr 25, 2025 0.01 0.00   
 Accentis S.A. D1Z Apr 25, 2025 0.03 -1.89   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
+

Cookie consent

We use cookies to give you a better user experience. If you continue to use the website, you accept this. For further details click here.